Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

March 30, 2026

General (Ret.) Frank McKenzie, Former CENTCOM Commander, Joins Pallas Speakers Bureau

March 30, 2026

MEXC Lists 20 New Ondo Tokenized Stocks with Zero-Fee Trading

March 30, 2026

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

March 30, 2026

Paraganglioma Market Trends and Investment Opportunities 2026-2030

March 30, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Signal AI Sharpens Reputation and Risk Capabilities with Acquisition of Social 360
Press Release

Signal AI Sharpens Reputation and Risk Capabilities with Acquisition of Social 360

By News RoomFebruary 15, 20244 Mins Read
Signal AI Sharpens Reputation and Risk Capabilities with Acquisition of Social 360
Share
Facebook Twitter LinkedIn Pinterest Email

LONDON and NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) — Signal AI, a global leader in Reputation and Risk Intelligence, announces the acquisition of Social 360, an advanced reputation intelligence monitoring company currently serving an international client base in the USA, EMEA, and APAC.

The acquisition will integrate traditional, social, regulatory, and alternative data sources into one unified platform. Social 360 analyses billions of pieces of online content from more than 90 million sources, which will complement Signal AI’s industry-leading monitoring platform. Social 360’s data sets include a broad range of fast-moving online content and data, including social media, political and regulatory content, and emerging alternative platforms. The combined companies will deliver valuable, actionable, C-suite level intelligence that synthesises online data to help companies manage corporate reputation, mitigate corporate risk, and ensure they have the relevant information to advance corporate priorities.

Together, the two companies’ capabilities will provide a single source of relevant data, allowing clients to cut through the noise, navigate complex risks and opportunities, and elevate their reputation effectively. Similar to Signal AI, Social 360 partners with many of the world’s largest companies on risk mitigation and reputation analysis, as well as providing support in major crises. Complementing Signal AI’s leading premium media data, Social 360 has built the largest premium source list of online voices that can directly impact the reputation of any organisation. This delivers more than 2.3 million articles of reputational relevance from over 185,000 individual sources per month.

Key strategic benefits of the acquisition include:

  • Elevating Reputation Management: through its technology platform and team of seasoned analysts, Social 360 has pioneered unique ways to monitor the digital landscape, including influential organisations and people, to strengthen clients’ online reputation.
  • Proactive Risk Monitoring: Leveraging Social 360’s experience in monitoring and analysing online activity for major global brands, this partnership expands Signal AI’s risk intelligence capabilities. The fusion of new technology, human analysis, and diverse datasets positions the unified platform as the single source of intelligence for companies to stay ahead of potential risks and crises.
  • Integrated Data Mastery: This strategic alliance consolidates diverse data sources into a single, industry-leading source of truth for reputation and risk insights. This integration empowers companies to make more informed decisions and continually refine their strategies.
  • Expanded product offering: Social 360 will bring a number of new product offerings to Signa AI, including its corporate influencer monitoring tool. Social 360 also offers pharmacovigilance expertise, giving pharmaceutical businesses proactive monitoring and reporting of adverse events.

Commenting on the acquisition, David Benigson, CEO at Signal AI, said, “We are thrilled to welcome longtime partner Social 360 into the Signal AI family. With Social 360’s capabilities and billions of data points integrated into our AI-powered platform, we are creating a new standard for reputation and risk management.”

Ryszard Bublik, CEO of Social 360, said: “This deal will create a business that has a 360 degree view of online content across every channel, giving clients unique visibility of the issues that matter for reputation and risk. The coming together of our different, innovative data sets will create a new model for digital monitoring.”

Signal AI is a global leader in AI-driven reputation and risk insights. The company serves over 40% of Fortune 500 companies, analysing external data across 226 markets and 75 languages to navigate industry trends, manage reputational shifts, and mitigate risks.

Social 360 is an online monitoring and analysis business focused on reputation and risk management. With more than a decade of experience, the company has supported global organisations, providing them with insights and actionable data from millions of online sources.

Media Contact:
Frank De Maria
[email protected]
+1 347 647 0284

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e7b52bb9-bbaf-4871-a43f-4c5edd8bf20b

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

General (Ret.) Frank McKenzie, Former CENTCOM Commander, Joins Pallas Speakers Bureau

MEXC Lists 20 New Ondo Tokenized Stocks with Zero-Fee Trading

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

Paraganglioma Market Trends and Investment Opportunities 2026-2030

Brian Ferdinand Joins Forbes Finance Council, Marking Key Milestone for EverForward Trading

Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 – Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

Editors Picks

General (Ret.) Frank McKenzie, Former CENTCOM Commander, Joins Pallas Speakers Bureau

March 30, 2026

MEXC Lists 20 New Ondo Tokenized Stocks with Zero-Fee Trading

March 30, 2026

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

March 30, 2026

Paraganglioma Market Trends and Investment Opportunities 2026-2030

March 30, 2026

Latest News

Brian Ferdinand Joins Forbes Finance Council, Marking Key Milestone for EverForward Trading

March 30, 2026

Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes

March 30, 2026

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 – Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

March 30, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version